Medicare GLP-1 program 6 weeks out introduces new workflows and volume spikes for health systems and pharmacies starting July 1, 2024.

There’s no shortage of headlines and hypotheticals about the blockbuster drug class of GLP-1s. Stephen Klasko, MD, argues we’re asking the wrong questions about GLP-1s. For health system leaders, the ...

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...

GoodRx reports that while satisfaction with GLP-1s for weight loss is high, costs and access issues significantly impact ...

President Donald Trump says Medicare will cover some GLP-1 drugs starting from July 1, potentially cutting costs to $50 a ...

The GLP-1 Agonists Market offers growth opportunities due to rising diabetes cases, innovations in drug delivery, and ...

Data analyses show that people with Type 2 diabetes using GLP-1 medicines saw a significant improvement in their HbA1C after adding FreeStyle Libre technology to their regimen Better HbA1c results ...

LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its MindBody ...

GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...

SoWell is unveiling GLP-1 Support System, a three-part supplement system designed specifically for GLP-1 users and their side effects. Alexandra Sowa, board-certified obesity medicine specialist, and ...